Free Trial
LON:BTG

BTG (BTG) Share Price, News & Analysis

BTG logo

About BTG Stock (LON:BTG)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
840
840
52-Week Range
N/A
Volume
271,742 shs
Average Volume
960,389 shs
Market Capitalization
£3.26 billion
P/E Ratio
29.47
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. The company was formerly known as British Technology Group International plc and changed its name to BTG plc in March 1995. BTG plc was founded in 1948 and is headquartered in London, the United Kingdom.

Remove Ads
Receive BTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BTG and its competitors with MarketBeat's FREE daily newsletter.

BTG Stock News Headlines

Arcos Dorados initiated with a Buy at BTG Pactual
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
See More Headlines

BTG Stock Analysis - Frequently Asked Questions

BTG plc (LON:BTG) released its quarterly earnings results on Tuesday, May, 15th. The company reported $32.90 earnings per share for the quarter, beating analysts' consensus estimates of $29.80 by $3.10.

Shares of BTG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that BTG investors own include Bodycote (BOY), Rapid7 (RPD), Editas Medicine (EDIT), Portola Pharmaceuticals (PTLA), Vectura Group (VEC), Bank of America (BAC) and B2Gold (BTO).

Company Calendar

Last Earnings
5/15/2018
Today
4/04/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Precious Metals
Current Symbol
LON:BTG
CIK
N/A
Fax
N/A
Employees
4,690
Year Founded
N/A

Profitability

Trailing P/E Ratio
29.47
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£914.10 million
Price / Cash Flow
9.25
Book Value
GBX 355.80 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£3.26 billion
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (LON:BTG) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners